Amar_a.ns (AMAR) > Trackbacks

Amarillo Biosciences, Inc.: ABI Outlines $5 Million Capital Raising Program to Complete Regulatory Approval of Oral Interferon

Tue, 26 Sep 2006 10:40:00 PDT

AMARILLO, TX (MARKET WIRE) Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR), today announced that it has commenced an effort to raise up to $5 Million to complete clinical studies of its low-dose oral interferon. Successful completion of these studies is necessary for ABI to apply for FDA approval.

Trackbacks

A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Amarillo Biosciences, Inc.: ABI Outlines $5 Million Capital Raising Program to Complete Regulatory Approval of Oral Interferon.

No trackbacks have been detected.

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.